Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Age-Related Memory Disorders

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Age-Related Memory Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, HZ; Dong, CZ; Gao, XL; Heymans, F; Huang, H; Li, J; Massicot, F; Miezan Ezoulin, JM1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Age-Related Memory Disorders

ArticleYear
Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity.
    The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:1

    Topics: Acetylcholinesterase; Animals; Binding, Competitive; Brain; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Humans; In Vitro Techniques; Male; Maze Learning; Memory; Memory Disorders; Mice; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Receptors, G-Protein-Coupled; Scopolamine; Space Perception

2007